California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

TIRUCHY: The early detection of Type 1 diabetes in children is improving due to enhanced school health screenings and ...

It said about a quarter of medicines dispensed by hospital pharmacies were for medication patients are already taking before ...

Merilog is a rapid-acting human insulin analog and the first rapid-acting insulin biosimilar ... Both a 3-mL ...

The approval is for both a 3 milliliter or mL single-patient-use prefilled pen and a 10 mL multiple-dose vial. As a rapid-acting human insulin, Merilog helps to lower mealtime blood sugar spikes ...

The approval is for both a 3 milliliter (mL) single-patient-use prefilled pen and a 10 milliliter (mL) multiple-dose vial. Merilog is the third insulin biosimilar product approved by the FDA and ...

The regulatory action makes Merilog the first rapid-acting insulin biosimilar to gain FDA approval. According to the federal agency, the approval includes both a prefilled pen and a multi-dose vial, ...